Description:
Next-generation therapeutics, including proteins (bispecific antibodies, therapeutic enzymes, CRISPR-Cas nucleases), viral vectors for gene therapy, and cells (stem cells, engineered T cells, etc.) are a new and exciting class of biotherapeutics. They are the way of the future. To enable this future, it is crucial to develop novel technologies for their isolation and purification from natural (animals or plants) or recombinant sources (cell culture fluids). A broad variety of topics are welcome: novel ligands and substrates, mobile phases and separation approaches (chromatographic vs.non-chromatographic), computational models, application of imaging and sensing techniques, and quality-by-design.
Sponsor:
Bio Separations
Co-Sponsor(s):
Food, Pharmaceutical & Bioengineering Division (15)
Chair:
Christoph Brandenbusch
Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, TU Dortmund, Dortmund, Germany
Co-Chair:
Maximilian Wessner
Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, TU Dortmund University, Dortmund, Germany
Abstract Submissions Closed
See more of this Group/Topical: Separations Division